相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cause-specific Mortality in a Population-based Cohort of 9799 Women Treated for Ductal Carcinoma In Situ
Lotte E. Elshof et al.
ANNALS OF SURGERY (2018)
The prevalence and clinical relevance of tumor-infiltrating lymphocytes (TILs) in ductal carcinoma in situ of the breast
G. Pruneri et al.
ANNALS OF ONCOLOGY (2017)
Clinical Utility of the 12-Gene DCIS Score Assay: Impact on Radiotherapy Recommendations for Patients with Ductal Carcinoma In Situ
Jennifer B. Manders et al.
ANNALS OF SURGICAL ONCOLOGY (2017)
Characterizing the immune microenvironment in high-risk ductal carcinoma in situ of the breast
Michael J. Campbell et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Further evidence to support bimodality of oestrogen receptor expression in breast cancer
Abir A. Muftah et al.
HISTOPATHOLOGY (2017)
Cause-specific mortality in women with breast cancer in situ
Wei He et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Prognostic significance of tumour infiltrating B lymphocytes in breast ductal carcinoma in situ
Islam Miligy et al.
HISTOPATHOLOGY (2017)
Multigene Expression Assay and Benefit of Radiotherapy After Breast Conservation in Ductal Carcinoma in Situ
Eileen Rakovitch et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Breast ductal carcinoma in situ carry mutational driver events representative of invasive breast cancer
Jia-Min B. Pang et al.
MODERN PATHOLOGY (2017)
Whole-genome single-cell copy number profiling from formalin-fixed paraffin-embedded samples
Luciano G. Martelotto et al.
NATURE MEDICINE (2017)
Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy
Teresa Davoli et al.
SCIENCE (2017)
Multigene Expression Assay and Benefit of Radiotherapy After Breast Conservation in Ductal Carcinoma in Situ
Eileen Rakovitch et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Relationship of the Breast Ductal Carcinoma In Situ Immune Microenvironment with Clinicopathological and Genetic Features
Shona Hendry et al.
CLINICAL CANCER RESEARCH (2017)
The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study aaaaaa
Lotte E. Elshof et al.
BREAST CANCER RESEARCH (2017)
An Examination of the Local Cellular Immune Response to Examples of Both Ductal Carcinoma In Situ (DCIS) of the Breast and DCIS With Microinvasion, With Emphasis on Tertiary Lymphoid Structures and Tumor Infiltrating Lymphoctytes
Ahrong Kim et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2016)
Risk prediction for local versus regional/metastatic tumors after initial ductal carcinoma in situ diagnosis treated by lumpectomy
Annette M. Molinaro et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Extent of ductal carcinoma in situ according to breast cancer subtypes: a population-based cohort study
Shusma C. Doebar et al.
BREAST CANCER RESEARCH AND TREATMENT (2016)
Predictors for local invasive recurrence of ductal carcinoma in situ of the breast: a meta-analysis
Xining Zhang et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2016)
Cost Effectiveness of the Oncotype DX DCIS Score for Guiding Treatment of PatientsWith Ductal Carcinoma In Situ
Ann C. Raldow et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Patient Prognostic Score and Associations With Survival Improvement Offered by Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma In Situ: A Population-Based Longitudinal Cohort Study
Yasuaki Sagara et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Screen detection of ductal carcinoma in situ and subsequent incidence of invasive interval breast cancers: a retrospective population-based study
Stephen W. Duffy et al.
LANCET ONCOLOGY (2016)
The immune microenvironment of breast ductal carcinoma in situ
Elizabeth Thompson et al.
MODERN PATHOLOGY (2016)
Tamoxifen Initiation After Ductal Carcinoma In Situ
Hazel B. Nichols et al.
ONCOLOGIST (2016)
Molecular Features of Subtype-Specific Progression from Ductal Carcinoma In Situ to Invasive Breast Cancer
Robert Lesurf et al.
CELL REPORTS (2016)
Her2 and Ki67 Biomarkers Predict Recurrence of Ductal Carcinoma in Situ
James E. Davis et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2016)
Molecular phenotypes of DCIS predict overall and invasive recurrence
K. E. Williams et al.
ANNALS OF ONCOLOGY (2015)
Risk of subsequent in situ and invasive breast cancer in human epidermal growth factor receptor 2-positive ductal carcinoma in situ
G. Curigliano et al.
ANNALS OF ONCOLOGY (2015)
Relationship Between Margin Width and Recurrence of Ductal Carcinoma In Situ Analysis of 2996 Women Treated With Breast-conserving Surgery for 30 Years
Kimberly J. Van Zee et al.
ANNALS OF SURGERY (2015)
Risk Prediction for Local Breast Cancer Recurrence Among Women with DCIS Treated in a Community Practice: A Nested, Case-Control Study
Laura C. Collins et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Long-term outcomes of ductal carcinoma in situ of the breast: a systematic review, meta-analysis and meta-regression analysis
Kirsty E. Stuart et al.
BMC CANCER (2015)
A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone
Eileen Rakovitch et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Cancer statistics: Breast cancer in situ
Elizabeth M. Ward et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
A Molecular Portrait of High-Grade Ductal Carcinoma In Situ
Martin C. Abba et al.
CANCER RESEARCH (2015)
Addressing Overtreatment in DCIS: What Should Physicians Do Now?
Monica Morrow et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Trends in Treatment Patterns and Outcomes for Ductal Carcinoma in Situ
Mathias Worni et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Correlation of histopathologic features of ductal carcinoma in situ of the breast with the oncotype DX DCIS score
Adriana Knopfelmacher et al.
MODERN PATHOLOGY (2015)
Copy number analysis of ductal carcinoma in situ with and without recurrence
Kylie L. Gorringe et al.
MODERN PATHOLOGY (2015)
Genomic differences between pure ductal carcinoma in situ and synchronous ductal carcinoma in situ with invasive breast cancer
Shinn Young Kim et al.
ONCOTARGET (2015)
DNA methylation in ductal carcinoma in situ related with future development of invasive breast cancer
Kevin C. Johnson et al.
CLINICAL EPIGENETICS (2015)
Addressing Overtreatment in DCIS: What Should Physicians Do Now?
Monica Morrow et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Trends in Treatment Patterns and Outcomes for Ductal Carcinoma in Situ
Mathias Worni et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ
Steven A. Narod et al.
JAMA ONCOLOGY (2015)
Continued observation of the natural history of low-grade ductal carcinoma in situ reaffirms proclivity for local recurrence even after more than 30 years of follow-up
Melinda E. Sanders et al.
MODERN PATHOLOGY (2015)
Chromosomal copy number alterations for associations of ductal carcinoma in situ with invasive breast cancer
Anosheh Afghahi et al.
BREAST CANCER RESEARCH (2015)
Risk of subsequent invasive breast cancer after a diagnosis of ductal carcinoma in situ (DCIS)
Shan Cheung et al.
BREAST (2014)
COX-2 expression is predictive for early relapse and aromatase inhibitor resistance in patients with ductal carcinoma in situ of the breast, and is a target for treatment
D. Generali et al.
BRITISH JOURNAL OF CANCER (2014)
Local Relapse After Breast-Conserving Therapy for Ductal Carcinoma In Situ
Caroline Sweldens et al.
CANCER JOURNAL (2014)
αvβ6 Expression in Myoepithelial Cells: A Novel Marker for Predicting DCIS Progression with Therapeutic Potential
Michael D. Allen et al.
CANCER RESEARCH (2014)
Altered Microenvironment Promotes Progression of Preinvasive Breast Cancer: Myoepithelial Expression of αvβ6 Integrin in DCIS Identifies High-risk Patients and Predicts Recurrence
Michael D. Allen et al.
CLINICAL CANCER RESEARCH (2014)
Ductal Carcinoma In Situ of the Breast: Can Biomarkers Improve Current Management?
John M. S. Bartlett et al.
CLINICAL CHEMISTRY (2014)
Validation of a Nomogram in the Prediction of Local Recurrence Risks after Conserving Surgery for Asian Women with Ductal Carcinoma in Situ of the Breast
F. Wang et al.
CLINICAL ONCOLOGY (2014)
Clonal alteration of breast cancer receptors between primary ductal carcinoma in situ (DCIS) and corresponding local events
E. Karlsson et al.
EUROPEAN JOURNAL OF CANCER (2014)
Stromal Fibroblasts and the Immune Microenvironment: Partners in Mammary Gland Biology and Pathology?
Ashleigh Unsworth et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2014)
Frequent phosphatidylinositol-3-kinase mutations in proliferative breast lesions
Daphne C. Ang et al.
MODERN PATHOLOGY (2014)
Genome-wide DNA methylation profiles in progression to
Thomas Fleischer et al.
GENOME BIOLOGY (2014)
Methylation profiling of ductal carcinoma in situ and its relationship to histopathological features
Jia-Min B. Pang et al.
BREAST CANCER RESEARCH (2014)
Molecular subtypes in ductal carcinoma in situ of the breast and their relation to prognosis: a population-based cohort study
Wenjing Zhou et al.
BMC CANCER (2013)
The penetrance of ductal carcinoma in situ among BRCA1 and BRCA2 mutation carriers
Emanuele Mazzola et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Stromal architecture and periductal decorin are potential prognostic markers for ipsilateral locoregional recurrence in ductal carcinoma in situ of the breast
Mieke Van Bockstal et al.
HISTOPATHOLOGY (2013)
Breast-Conserving Treatment With or Without Radiotherapy in Ductal Carcinoma In Situ: 15-Year Recurrence Rates and Outcome After a Recurrence, From the EORTC 10853 Randomized Phase III Trial
Mila Donker et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
A Multigene Expression Assay to Predict Local Recurrence Risk for Ductal Carcinoma In Situ of the Breast
Lawrence J. Solin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2013)
Predictors of recurrence for ductal carcinoma in situ after breast-conserving surgery
John R. Benson et al.
LANCET ONCOLOGY (2013)
A Nation-Wide Multicenter Retrospective Study of the Epidemiological, Pathological and Clinical Characteristics of Breast Cancer In Situ in Chinese Women in 1999-2008
Yanan Kong et al.
PLOS ONE (2013)
Biofunctional characteristics of in situ and invasive breast carcinoma
Sara Bravaccini et al.
CELLULAR ONCOLOGY (2013)
A Comparison of Tumor Biology in Primary Ductal Carcinoma In Situ Recurring as Invasive Carcinoma versus a New In Situ
Wenjing Zhou et al.
INTERNATIONAL JOURNAL OF BREAST CANCER (2013)
DNA methylation in ductal carcinoma in situ of the breast
Jia-Min B. Pang et al.
BREAST CANCER RESEARCH (2013)
Management of ductal carcinoma in situ according to Van Nuys Prognostic Index in Australia and New Zealand
Robert Whitfield et al.
ANZ JOURNAL OF SURGERY (2012)
Use of trastuzumab in Australia and New Zealand: results from the National Breast Cancer Audit
Robert Whitfield et al.
ANZ JOURNAL OF SURGERY (2012)
Identification of copy number alterations associated with the progression of DCIS to invasive ductal carcinoma
Clint E. Johnson et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression
Ana Cristina Vargas et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
HER2/neu and Ki-67 expression predict non-invasive recurrence following breast-conserving therapy for ductal carcinoma in situ
E. Rakovitch et al.
BRITISH JOURNAL OF CANCER (2012)
Differentially Expressed Genes Regulating the Progression of Ductal Carcinoma In Situ to Invasive Breast Cancer
Sangjun Lee et al.
CANCER RESEARCH (2012)
Genome-wide methylation screen in low-grade breast cancer identifies novel epigenetically altered genes as potential biomarkers for tumor diagnosis
Marta Faryna et al.
FASEB JOURNAL (2012)
Evaluation of a Breast Cancer Nomogram for Predicting Risk of Ipsilateral Breast Tumor Recurrences in Patients With Ductal Carcinoma in Situ After Local Excision
Min Yi et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Genomic and mutational profiling of ductal carcinomas in situ and matched adjacent invasive breast cancers reveals intra-tumour genetic heterogeneity and clonal selection
Lucia Hernandez et al.
JOURNAL OF PATHOLOGY (2012)
Sequence analysis of mutations and translocations across breast cancer subtypes
Shantanu Banerji et al.
NATURE (2012)
Comprehensive molecular portraits of human breast tumours
Daniel C. Koboldt et al.
NATURE (2012)
Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA
Stefano Volinia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Association of RB/p16-Pathway Perturbations with DCIS Recurrence Dependence on Tumor versus Tissue Microenvironment
Agnieszka K. Witkiewicz et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Different Distribution of Breast Cancer Subtypes in Breast Ductal Carcinoma in situ (DCIS), DCIS with Microinvasion, and DCIS with Invasion Component
Ke-Da Yu et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Outcomes of Screening-Detected Ductal Carcinoma In Situ Treated with Wide Excision Alone
Jonathan Fong et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Tumor characteristics as predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis
Shi-Yi Wang et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Second events following ductal carcinoma in situ of the breast: a register-based cohort study
Ragnhild Sorum Falk et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease
S. E. Clark et al.
BRITISH JOURNAL OF CANCER (2011)
Long-Term Outcomes of Invasive Ipsilateral Breast Tumor Recurrences After Lumpectomy in NSABP B-17 and B-24 Randomized Clinical Trials for DCIS
Irene L. Wapnir et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial
Jack Cuzick et al.
LANCET ONCOLOGY (2011)
Ductal Carcinoma in Situ at Core-Needle Biopsy: Meta-Analysis of Underestimation and Predictors of Invasive Breast Cancer
Meagan E. Brennan et al.
RADIOLOGY (2011)
Promoter CpG island hypermethylation during breast cancer progression
So Yeon Park et al.
VIRCHOWS ARCHIV (2011)
Biological Markers in DCIS and Risk of Breast Recurrence: A Systematic Review
Sara A. Lari et al.
JOURNAL OF CANCER (2011)
Gene amplification in ductal carcinoma in situ of the breast
L. Burkhardt et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Analysis of stromal signatures in the tumor microenvironment of ductal carcinoma in situ
M. Sharma et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Stromal CD10 and SPARC expression in ductal carcinoma in situ (DCIS) patients predicts disease recurrence
Agnieszka K. Witkiewicz et al.
CANCER BIOLOGY & THERAPY (2010)
PIK3CA Mutations in In situ and Invasive Breast Carcinomas
Alexander Miron et al.
CANCER RESEARCH (2010)
PIK3CA mutations mostly begin to develop in ductal carcinoma of the breast
Hua Li et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2010)
Breast cancer precursors revisited: molecular features and progression pathways
Maria A. Lopez-Garcia et al.
HISTOPATHOLOGY (2010)
Expression of metalloproteases and their inhibitors by tumor and stromal cells in ductal carcinoma in situ of the breast and their relationship with microinvasive events
L. O. Gonzalez et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Nomogram for Predicting the Risk of Local Recurrence After Breast-Conserving Surgery for Ductal Carcinoma In Situ
Udo Rudloff et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Biomarker Expression and Risk of Subsequent Tumors After Initial Ductal Carcinoma In Situ Diagnosis
Karla Kerlikowske et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Genetic mutations and expression of p53 in non-invasive breast lesions
Xiaoyun Mao et al.
MOLECULAR MEDICINE REPORTS (2010)
Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer
Aslaug Aamodt Muggerud et al.
MOLECULAR ONCOLOGY (2010)
PIK3CA mutations associated with gene signature of low mTORC1 signaling and better outcomes in estrogen receptor-positive breast cancer
Sherene Loi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Frequent aberrant DNA methylation of ABCB1, FOXC1, PPP2R2B and PTEN in ductal carcinoma in situ and early invasive breast cancer
Aslaug Aa Muggerud et al.
BREAST CANCER RESEARCH (2010)
PIK3CA Mutation Associates with Improved Outcome in Breast Cancer
Kevin Kalinsky et al.
CLINICAL CANCER RESEARCH (2009)
Early and Locally Advanced Breast Cancer: Diagnosis and Treatment National Institute for Health and Clinical Excellence Guideline 2009
J. Yarnold
CLINICAL ONCOLOGY (2009)
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
Maggie C. U. Cheang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Role of COX-2 in epithelial-stromal cell interactions and progression of ductal carcinoma in situ of the breast
Min Hua et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Methylation of homeobox genes is a frequent and early epigenetic event in breast cancer
Stella Tommasi et al.
BREAST CANCER RESEARCH (2009)
Gene expression profiling of the tumor microenvironment during breast cancer progression
Xiao-Jun Ma et al.
BREAST CANCER RESEARCH (2009)
COX-2 and PPARγ expression are potential markers of recurrence risk in mammary duct carcinoma in-situ
Swati Kulkarni et al.
BMC CANCER (2008)
Regulation of in situ to invasive breast carcinoma transition
Min Hu et al.
CANCER CELL (2008)
Molecular Grading of Ductal Carcinoma In situ of the Breast
Rosemary L. Balleine et al.
CLINICAL CANCER RESEARCH (2008)
Integrated genomic and transcriptomic analysis of ductal carcinoma in situ of the breast
Anne Vincent-Salomon et al.
CLINICAL CANCER RESEARCH (2008)
Ductal carcinoma in situ and the emergence of diversity during breast cancer evolution
D. Craig Allred et al.
CLINICAL CANCER RESEARCH (2008)
The significance of the Van Nuys prognostic index in the management of ductal carcinoma in situ
Onur Gilleard et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2008)
259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up
Salomone Di Saverio et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Immunohistochemical categorisation of ductal carcinoma in situ of the breast
P. Meijnen et al.
BRITISH JOURNAL OF CANCER (2008)
Clinical outcome after selective treatment of patients diagnosed with ductal carcinoma in situ of the breast
Philip Meijnen et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer
Rulla M. Tamimi et al.
BREAST CANCER RESEARCH (2008)
An attempt to independently verify the utility of the Van Nuys Prognostic Index for ductal carcinoma in situ
Stephanie G. MacAusland et al.
CANCER (2007)
Abrogated response to cellular stress identifies DCIS associated with subsequent tumor events and def ines basal-like breast tumors
Mona L. Gauthier et al.
CANCER CELL (2007)
Ductal carcinoma in situ of the breast (DCIS) with heterogeneity of nuclear grade:: prognostic effects of quantitative nuclear assessment
Judith-Anne W. Chapman et al.
BMC CANCER (2007)
Stromal cells associated with early invasive foci in human mammary ductal carcinoma in situ coexpress urokinase and urokinase receptor
Boye S. Nielsen et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Ductal carcinoma in situ in BRCA mutation carriers
E. Shelley Hwang et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Magnetic resonance imaging captures the biology of ductal carcinoma in situ
Laura J. Esserman et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Rationalization and regionalization of treatment for ductal carcinoma in situ of the breast
Grace L. Smith et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
The natural history of ductal carcinoma in situ of the breast:: a review
B Erbas et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Impact of a national external quality assessment scheme for breast pathology in the UK
IO Ellis et al.
JOURNAL OF CLINICAL PATHOLOGY (2006)
Survivin expression in in situ and invasive breast cancer relates to COX-2 expression and DCIS recurrence
N Barnes et al.
BRITISH JOURNAL OF CANCER (2006)
Classification of ductal carcinoma in situ by gene expression profiling
Juliane Hannemann et al.
BREAST CANCER RESEARCH (2006)
Patient involvement in surgery treatment decisions for breast cancer
SJ Katz et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy - Results from the Nurses' Health Study
LC Collins et al.
CANCER (2005)
Grade of recurrent in situ and invasive carcinoma following treatment of pure ductal carcinoma in situ of the breast
RR Millis et al.
BRITISH JOURNAL OF CANCER (2004)
Patterns of chromosomal alterations in breast ductal carcinoma in situ
ES Hwang et al.
CLINICAL CANCER RESEARCH (2004)
Molecular characterization of the tumor microenvironment in breast cancer
M Allinen et al.
CANCER CELL (2004)
DNA methylation of RASSF1A, Hin-1, RAR-β, cyclin D2 and twist in in situ and invasive lobular breast carcinoma
MJ Fackler et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Loss of heterozygosity analyses of asynchronous lesions of ductal carcinoma in situ and invasive ductal carcinoma of the human breast
M Amari et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2003)
The University of Southern California/Van Nuys prognostic index for ductal carcinoma in situ of the breast
MJ Silverstein
AMERICAN JOURNAL OF SURGERY (2003)
Value of the Van Nuys Prognostic Index in prediction of recurrence of ductal carcinoma in situ after breast-conserving surgery
GP Boland et al.
BRITISH JOURNAL OF SURGERY (2003)
Epithelial lesions in prophylactic mastectomy specimens from women with BRCA mutations
ND Kauff et al.
CANCER (2003)
Breast ductal carcinoma in situ with microinvasion -: A definition supported by a long-term study of 1248 serially sectioned ductal carcinomas
I de Mascarel et al.
CANCER (2002)
Genetic pathways in the evolution of breast ductal carcinoma in situ
F Farabegoli et al.
JOURNAL OF PATHOLOGY (2002)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele loss
A Maitra et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
p53 missense mutations in microdissected high-grade ductal carcinoma in situ of the breast
SJ Done et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Variations in diagnostic and therapeutic procedures in a multicentre, randomized clinical trial (EORTC 10853) investigating breast-conserving treatment for DCIS
N Bijker et al.
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY (2001)
Histological type and marker expression of the primary tumour compared with its local recurrence after breast-conserving therapy for ductal carcinoma in situ
N Bijker et al.
BRITISH JOURNAL OF CANCER (2001)
Chromosomal alterations in ductal carcinomas in situ and their in situ recurrences
FM Waldman et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
